KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Net Income towards Common Stockholders: 2009-2025

Historic Net Income towards Common Stockholders for Idexx Laboratories (IDXX) over the last 17 years, with Sep 2025 value amounting to $274.6 million.

  • Idexx Laboratories' Net Income towards Common Stockholders rose 17.94% to $274.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 18.61%. This contributed to the annual value of $887.9 million for FY2024, which is 5.07% up from last year.
  • Idexx Laboratories' Net Income towards Common Stockholders amounted to $274.6 million in Q3 2025, which was down 6.59% from $294.0 million recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Net Income towards Common Stockholders registered a high of $294.0 million during Q2 2025, and its lowest value of $132.0 million during Q2 2022.
  • Moreover, its 3-year median value for Net Income towards Common Stockholders was $224.2 million (2023), whereas its average is $231.3 million.
  • Per our database at Business Quant, Idexx Laboratories' Net Income towards Common Stockholders spiked by 82.60% in 2021 and then crashed by 34.61% in 2022.
  • Over the past 5 years, Idexx Laboratories' Net Income towards Common Stockholders (Quarterly) stood at $162.8 million in 2021, then increased by 5.80% to $172.2 million in 2022, then climbed by 12.96% to $194.5 million in 2023, then climbed by 11.12% to $216.1 million in 2024, then grew by 17.94% to $274.6 million in 2025.
  • Its Net Income towards Common Stockholders stands at $274.6 million for Q3 2025, versus $294.0 million for Q2 2025 and $242.7 million for Q1 2025.